Domestic pharmaceutical companies have failed on the patent nullity of Baraclude

As Daewoong Pharmaceutical and Hanmi Pharmaceutical have failed on the substance patent nullity of Baraclude, domestic pharmaceutical companies’ exclusive sale rights have also been blown away, too.

If the substance patent of Baraclude was nullified, several domestic pharmaceutical companies could have acquired exclusive sale rights for Baraclude generics for a year if the Prioritized Sale Pro...